| Financial Year |
March 31 2023 |
| Monetary Funds |
530,288,819.53 |
| Held-for-trading Financial Assets |
494,660,523.18 |
| Notes Receivable |
10,704,048.18 |
| Accounts Receivable |
161,679,209.66 |
| Advances to Suppliers |
767,350.64 |
| Other Receivables |
6,841,789.52 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
-- |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
50,000,000.00 |
| Other Current Assets |
1,117,159.34 |
| Total Current Assets |
1,530,241,811.66 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
10,718,089.88 |
| Fixed Assetes |
193,531,156.04 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
10,025,214.02 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
4,437,846.73 |
| Deferred Income Tax Assets |
18,552,857.86 |
| Other Non-Current Assets |
95,259,674.10 |
| Sub-Total of Non-Current Assets |
363,101,075.39 |
| Total Assets |
1,893,342,887.05 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
67,038,935.25 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
98,545,149.65 |
| Taxes Payable |
13,400,674.96 |
| Interest Payable |
-- |
| Dividend Payable |
1,644,000.00 |
| Other payables |
35,161,620.32 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
6,285,555.03 |
| Other Current Liabilities |
16,972,010.02 |
| Sub-Total of Current Liabilities |
520,270,779.06 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
19,176,180.95 |
| Total Liabilities |
539,446,960.01 |
| Paid-In Capital(Or Share Stock) |
164,384,000.00 |
| Capital Surplus |
570,509,717.22 |
| Surplus Reserve |
71,054,651.62 |
| LESS:Treasury Stock |
32,249,800.00 |
| Undistributed Profits |
580,197,358.20 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,353,895,927.04 |
| Owner's Equity（Stockholder's Equity） |
1,353,895,927.04 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,893,342,887.05 |
